CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Medifron DBT Co Ltd Company Snapshot
Medifron DBT Co Ltd operates in the Computers, peripherals & software sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medifron DBT Co Ltd with three other companies in this sector in KOREA (SOUTH) : SGA Embedded Co Ltd (2019 sales of 19.47 billion Korean Won [US$16.57 million] ), Pobis TNC Company Limited (20.41 billion Korean Won [US$17.36 million] of which 91% was Other), and KidariStudio Inc (26.74 billion Korean Won [US$22.75 million] of which 100% was Media Contents).

Sales Analysis. Medifron DBT Co Ltd reported sales of 17.41 billion Korean Won (US$14.82 million) for the year ending December of 2019. This represents a decrease of 12.5% versus 2018, when the company's sales were 19.89 billion Korean Won . Contributing to the drop in overall sales was the 94.7% decline in Medicine Business, from 24.54 million Korean Won to 1.30 million Korean Won . There were also decreases in sales in It Business (down 12.4% to 17.41 billion Korean Won ) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Medifron DBT Co Ltd
  Stock Performance Chart for Medifron DBT Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 4,705.00
(Figures in Korean Won )
1 Week -6.1%   13 Weeks -3.1%  
4 Weeks 22.4%   52 Weeks 5.3%  
 
Medifron DBT Co Ltd Key Data:
  Ticker: 065650 Country: Korea (South)
  Exchanges: SEO Major Industry: Retailing
    Sub Industry: Computers, Peripherals & Software
  2019 Sales 17,412,906,478
(Year Ending Jan 2020).
Employees: 22
  Currency: Korean Won Market Cap: 175,025,388,350
  Fiscal Yr Ends: December Shares Outstanding: 37,199,870
  Share Type: Common Closely Held Shares: 1,515,989
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.